✦ LIBER ✦

101 High levels of HBsAg clearance after adefovir dipivoxil treatment in patients with chronic hepatitis B lamivudine-resistant post liver transplant

Book ID: 117373613
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 106 KB
Volume: 42
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)81513-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Lamivudine-Resistant Hepati

Treatment of Lamivudine-Resistant Hepatitis B Infection in Post–Renal Transplant Patients With Adefovir Dipivoxil: Premiminary Results

✍ H.J. de Silva; A.S. Dassanayake; A. Manamperi; A.P. de Silva 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 150 KB

2 Safety and efficacy of adefovir dipivo

2 Safety and efficacy of adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B undergoing liver transplantation

✍ E. Schiff; C.L. Lai; P. Neuhaus; H. Tillman; D. Samuel; J.P. Villeneuve; S. Hadz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 108 KB

10 Resistance surveillance of liver tran

10 Resistance surveillance of liver transplantation patients with lamivudine-resistant hepatitis B virus (HBV) after 96 weeks of adefovir dipivoxil treatment

✍ Christopher E. Westland; Jean-Pierre Villeneuve; Norah A. Terrault; Fabien Zouli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

11 Adefovir dipivoxil 10 MG (ADV) for th

11 Adefovir dipivoxil 10 MG (ADV) for the treatment of chronic hepatitis B in patients pre-liver transplantation with lamivudine-resistant patients

✍ Eurgen Schiff; Ching-Lung Lai; Stefanos Hadziyannis; Peter Neuhaus; Norah Terrau 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Increased risk of adefovir resistance in

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy

✍ Yoon-Seon Lee; Dong Jin Suh; Young-Suk Lim; Suk Won Jung; Kang Mo Kim; Han Chu L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

Although adefovir dipivoxil (ADV) has a unique profile of delayed and infrequent resistance in treatment-naïve chronic hepatitis B patients, the association of ADV resistance with previous lamivudine (LAM) resistance is not well understood. We compared the emergence of the ADV-resistant mutations rt

Study on the Efficacy and Safety of Adef

Study on the Efficacy and Safety of Adefovir Dipivoxil Treatment in Post–Liver Transplant Patients With Hepatitis B Virus Infection and Lamivudine-Resistant Hepatitis B Virus

✍ R. Bárcena; S. Del Campo; G. Moraleda; T. Casanovas; M. Prieto; M. Buti; J.M. Mo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 61 KB